| [1] | McCalman P (2001) Reaping what you sow: an empirical analysis of international patent harmonization. Journal of International Economics 55: 161–186.
|
| [2] | Maskus K, Reichman J (eds.) (2005) International Public Goods And Transfer Of Technology Under A Globalized Intellectual Property Regime. Cambridge, UK: Cambridge University Press.
|
| [3] | Correa CM (2007) Trade related aspects of intellectual property rights: a commentary on the TRIPS agreement. Oxford; New York: Oxford University Press.
|
| [4] | Dutfield G (2000) Intellectual Property Rights, Trade and Biodiversity: Seeds and Plant Varieties. London: Earthscan.
|
| [5] | Dutfield G (2004) Intellectual property, biogenetic resources, and traditional knowledge. London: Earthscan.
|
| [6] | Hall BH (2007) Patents and patent policy. Oxford Review Of Economic Policy 23: 568–587.
|
| [7] | Kamiyama S, Sheehan J, Martinez C (2006) Valuation And Exploitation of Intellectual Property. STI Working Paper 2006/5. Paris: Organisation for Economic Co-operation and Development.
|
| [8] | Yanagisawa T, Guellec D (2009) The Emerging Patent Marketplace. STI Working Paper 2009/9. Paris: Organisation for Economic Co-operation and Development.
|
| [9] | WIPO Patent Cooperation Treaty Contracting States.
|
| [10] | Dam KW (1994) The Economic Underpinnings of Patent-Law. Journal of Legal Studies 23: 247–271.
|
| [11] | Denicolo V, Franzoni LA (2004) The contract theory of patents. International Review of Law and Economics 23: 365–380.
|
| [12] | Arora A, Ceccagnoli M, Cohen WM (2008) R&D and the patent premium. International Journal of Industrial Organization 26: 1153–1179.
|
| [13] | Moser P (2013) Patents and Innovation: Evidence from Economic History. Journal of Economic Perspectives 27: 23–44.
|
| [14] | Beuzekom B, Arundel A (2006) OECD Biotechnology Statistics - 2006. Paris: Organisation for Economic Co-operation and Development.
|
| [15] | Hall BH, Harhoff D (2012) Recent Research on the Economics of Patents. Annual Review of Economics 4: 541–565.
|
| [16] | Helpman E (1993) Innovation, Imitation, and Intellectual Property Rights. Econometrica 61: 1247–1280.
|
| [17] | Lee JY, Mansfield E (1996) Intellectual property protection and US foreign direct investment. Review of Economics and Statistics 78: 181–186.
|
| [18] | AlAzzawi S (2012) Innovation, productivity and foreign direct investment-induced R&D spillovers. Journal of International Trade & Economic Development 21 (5): 615–653.
|
| [19] | Lemley MA (2005) Property, intellectual property, and free riding. Texas Law Review 83: 1031–1075.
|
| [20] | Fleisher BM, McGuire WH, Smith AN, Zhou M (2013) Patent law, TRIPS, and economic growth: evidence from China. Asia-Pacific Journal of Accounting & Economics 20: 4–19.
|
| [21] | Branstetter L (2000) Foreign direct investment and R&D spillovers - Is there a connection? Role of Foreign Direct Investment in East Asian Economic Development 9: 113–146.
|
| [22] | Briggs K (2013) Does patent harmonization impact the decision and volume of high technology trade? International Review of Economics & Finance 25: 35–51.
|
| [23] | Park WG (2012) North-South models of intellectual property rights: an empirical critique. Review of World Economics 148: 151–180.
|
| [24] | Ang JB, Madsen JB (2013) International R&D Spillovers and Productivity Trends in the Asian Miracle Economies. Economic Inquiry 51: 1523–1541.
|
| [25] | Coe DT, Helpman E, Hoffmaister AW (1997) North-south R&D spillovers. Economic Journal 107: 134–149.
|
| [26] | Coe DT, Helpman E, Hoffmaister AW (2009) International R&D spillovers and institutions. European Economic Review 53: 723–741.
|
| [27] | Heller MA, Eisenberg RS (1998) Can Patents Deter Innovation? The Anticommons in Biomedical Research. Science 280: 698.
|
| [28] | Helfer LR (2004) Regime shifting: the TRIPS Agreement and new dynamics of international intellectual property lawmaking. The Yale Journal of International Law 29: 1–83.
|
| [29] | Safrin S (2004) Hyperownership in a Time of Biotechnological Promise: The International Conflict to Control the Building Blocks of Life. American Journal of International Law 98: 641–685.
|
| [30] | Eisenberg RS (1996) Intellectual property issues in genomics. Trends In Biotechnology 14: 302–307.
|
| [31] | Royal Society (2003) Keeping Science Open: The Effects of Intellectual Property on the Conduct of Science. London: The Royal Society.
|
| [32] | Eisenberg RS (2003) Reaching through the genome. Advances in Genetics 50: 209–230.
|
| [33] | Azoulay P, Ding W, Stuart T (2009) The Impact of Academic Patenting on the Rate, Quality and Direction of (Public) Research Output. Journal Of Industrial Economics 57: 637–676.
|
| [34] | National Research Council (1997) Intellectual Property Rights and Research Tools in Molecular Biology: Summary of a Workshop Held at the National Academy of Sciences, February 15–16, 1996. Washington, DC.: The National Academies Press.
|
| [35] | Marshall E (1998) Biomedical patents - Making research tools more accessible. Science 280: 1687–1688.
|
| [36] | Rai AK (2002) Genome patents: A case study in patenting research tools. Academic Medicine 77: 1368–1372.
|
| [37] | Barton JH (2002) Research-tool patents: issues for health in the developing world. Bulletin of the World Health Organization 80: 121–125.
|
| [38] | O’Malley MA, Bostanci A, Calvert L (2005) Whole-genome patenting. Nature Reviews Genetics 6: 502–506.
|
| [39] | Holman C (2006) Clearing a path through the patent thicket. Cell 125: 629–633.
|
| [40] | Huang KG, Murray FE (2009) Does Patent Strategy Shape the Long-Run Supply of Public Knowledge? Evidence from Human Genetics. Academy of Management Journal 52 (6): 1193–1221.
|
| [41] | Chandrasekharan S, Cook-Deegan R (2009) Gene patents and personalized medicine - what lies ahead? Genome Medicine 1: 92.
|
| [42] | Kean Sam (2011) The Human Genome (Patent) Project. Science 331: 530.
|
| [43] | Kennedy D (2001) Enclosing the research commons. Science 294: 2249–2249.
|
| [44] | Boyle J (2003) The second enclosure movement and the construction of the public domain. Law and Contemporary Problems 66: 33–74.
|
| [45] | Chander A, Sunder M (2004) The romance of the public domain. California Law Review 92: 1331–1373.
|
| [46] | Benkler Yochai (2004) Commons-Based Strategies and the Problems of Patents. Science 305: 1110.
|
| [47] | Triggle DJ (2004) Patenting the sun: Enclosing the scientific commons and transforming the university - Ethical concerns. Drug Development Research 63: 139–149.
|
| [48] | Cook-Deegan R (2007) The science commons in health research: structure, function, and value. Journal of Technology Transfer 32: 133–156.
|
| [49] | Hope J (2009) Biobazaar: the open source revolution and biotechnology. Cambridge, Mass: Harvard University Press.
|
| [50] | Overwalle GV (ed.) (2009) Gene patents and collaborative licensing models: patent pools, clearinghouses, open source models, and liability regimes. Cambridge, UK; New York: Cambridge University Press.
|
| [51] | Sugumaran G (2012) Open Source Drug Discovery - redefining IPR through open source innovations. Current Science 102 (12): 1637–1639.
|
| [52] | Halewood M, Noriega IL, Louafi S (2012) Crop Genetic Resources as a Global Commons: Challenges in International Law and Governance. London: Earthscan.
|
| [53] | Cook-Deegan R, DeRienzo C, Carbone J, Chandrasekharan S, Heaney C, et al. (2010) Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: Comparing breast and ovarian cancers with colon cancers. Genetics in Medicine 12: S15–S38.
|
| [54] | Golden JM (2010) WARF’s Stem Cell Patents and Tensions between Public and Private Sector Approaches to Research. Journal of Law Medicine & Ethics 38 (2): 314–331.
|
| [55] | Rai A, Boyle J (2007) Synthetic biology: Caught between property rights, the public domain, and the commons. PLoS Biology 5: 389–393.
|
| [56] | Calvert J (2008) The Commodification of Emergence: Systems Biology, Synthetic Biology and Intellectual Property. Biosocieties 3: 383–398.
|
| [57] | Taubes G (1995) Scientists Attacked for ‘Patenting’ Pacific Tribe. Science 270: 1112–1112.
|
| [58] | Posey DA, Dutfield G (1996) Beyond intellectual property: toward traditional resource rights for indigenous peoples and local communities. Ottawa, ON, Canada: International Development Research Centre.
|
| [59] | Dutfield G (2000) The public and private domains - Intellectual property rights in traditional knowledge. Science Communication 21: 274–295.
|
| [60] | Reardon J (2005) Race to the Finish: Identity and Governance in an Age of Genomics. Princeton, NJ: Princeton University Press.
|
| [61] | Abbott A (2011) Europe rules against stem-cell patents. Nature 471: 280.
|
| [62] | Orti L, Carbajo RJ, Pieper U, Eswar N, Maurer SM, et al. (2009) A Kernel for Open Source Drug Discovery in Tropical Diseases. PLoS Negl Trop Dis 3(4): e418 doi:10.1371/journal.pntd.0000418.
|
| [63] | Grover A, Citro B, Mankad M, Lander F (2012) Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health. Journal Of Law Medicine & Ethics 40 (2): 234–250.
|
| [64] | Beall R, Kuhn R (2012) Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis. PLoS Medicine 9(1): e1001154 doi:10.1371/journal.pmed.1001154.
|
| [65] | Hellerstein R (2012) What do drug monopolies cost consumers in developing countries? Economics Letters 116 (1): 108–111.
|
| [66] | Kuhn R, Beall RF (2012) The time for pharmaceutical compulsory licensing has expired. Nature Medicine 18: 1168–1168.
|
| [67] | Moon S, Bermudez J, ‘t Hoen E (2012) Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System? PLoS Medicine 9 5: e1001218 Doi:10.1371/journal.pmed.1001218.
|
| [68] | Wilson J (2007) GM crops: Patently wrong? Journal Of Agricultural & Environmental Ethics 20 (3): 261–283.
|
| [69] | Tansey G, Rajotte T (2008) The Future Control of Food: A Guide to International Negotiations and Rules on Intellectual Property, Biodiversity and Food Security. London: Earthscan.
|
| [70] | Blakeney M (2011) Recent developments in intellectual property and power in the private sector related to food and agriculture. Food Policy 36 (S1): S109–S113.
|
| [71] | Chiarolla C (2011) Intellectual Property, Agriculture and the World Food Crisis: the privatisation of crop biodiversity. Cheltenham: Edward Elgar Publishing.
|
| [72] | Shiva V (1997) Biopiracy: the plunder of nature and knowledge. Boston, MA: South End Press.
|
| [73] | Dutfield G (2000) Bioprospecting or biopiracy? Biofutur 204: 42–45.
|
| [74] | Ten Kate K, Laird SA (1999) The Commercial Use of Biodiversity: Access to Genetic Resources and Benefit-Sharing. London: Earthscan.
|
| [75] | Sheridan C (2005) EPO neem patent revocation revives biopiracy debate. Nature Biotechnology 23: 511–512.
|
| [76] | Hamilton C (2006) Biodiversity, biopiracy and benefits: What allegations of biopiracy tell us about intellectual property. Developing World Bioethics 6 (3): 158–173.
|
| [77] | Robinson DF (2010) Confronting biopiracy: challenges, cases and international debates. London: Earthscan.
|
| [78] | Buck M, Hamilton C (2011) The Nagoya Protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization to the Convention on Biological Diversity. Review of European Community & International Environmental Law 20: 47–61.
|
| [79] | Oliva MJ (2011) Sharing the Benefits of Biodiversity: A New International Protocol and its Implications for Research and Development. Planta Med 77: 1221–1227.
|
| [80] | Soares J (2011) The Nagoya Protocol and Natural Product-Based Research. ACS Chemical Biology 6: 289–289.
|
| [81] | Nijar GS (2011) The Nagoya Protocol on Access and Benefit Sharing of Genetic Resources: Analysis and Implementation Options for Developing Countries. Research Papers 36. South Centre and CEBLAW.
|
| [82] | Coombe RJ (2005) Protecting Traditional Environmental Knowledge and New Social Movements in the Americas: Intellectual Property, Human Right, or Claims to an Alternative Form of Sustainable Development. Florida Journal of International Law 17: 115–136.
|
| [83] | Cooper HD (2002) The international treaty on plant genetic resources for food and agriculture. Review of European Community & International Environmental Law 11: 1–16.
|
| [84] | Falcon WP, Fowler C (2002) Carving up the commons - emergence of a new international regime for germplasm development and transfer. Food Policy 27: 197–222.
|
| [85] | Cohen J, Dibner MS, Wilson A (2010) Development of and Access to Products for Neglected Diseases. PLoS One 5(5): e10610 doi:10.1371/journal.pone.0010610.
|
| [86] | ‘t Hoen E, Passarelli CA (2013) The role of intellectual property rights in treatment access: challenges and solutions. Current Opinion in HIV and AIDS 8: 70–74.
|
| [87] | Fidler DP (2010) Negotiating equitable access to influenza vaccines: Global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. PLoS Medicine 7: e1000247 doi:10.1371/Journal.Pmed.1000247.
|
| [88] | Arnaud-Haond S, Arrieta JM, Duarte CM (2011) Marine Biodiversity and Gene Patents. Science 331: 1521.
|
| [89] | Arrieta JM, Arnaud-Haond S, Duarte CM (2010) What lies underneath: Conserving the oceans’ genetic resources. Proc. Natl. Acad. Sci. USA 107: 18318–18324.
|
| [90] | Lohan D, Johnston S (2003) The international regime for bioprospecting: existing policies and emerging issues for Antarctica. Tokyo: United Nations University Institute of Advanced Studies.
|
| [91] | Herber BP (2006) Bioprospecting in Antarctica: the search for a policy regime. Polar Record 42: 139–146.
|
| [92] | Tvedt MW (2011) Patent law and bioprospecting in Antarctica. Polar Record 47: 46–55.
|
| [93] | Taubman A, Wager H, Watal J (2012) A handbook on the WTO TRIPS agreement. Cambridge; New York: Cambridge University Press.
|
| [94] | Secretariat of the World Trade Organization (2006) The Relationship Between the TRIPS Agreement and the Convention on Biological Diversity: Summary of Issues Raised and Points Made. Document IP/C/W/368/Rev.1. World Trade Organization.
|
| [95] | World Trade Organization (2011) Draft Decision to Enhance Mutual Supportiveness Between the TRIPS Agreement and the Convention on Biological Diversity. Communication from Brazil, China, Colombia, Ecuador, India, Indonesia, Peru, Thailand, the ACP Group, and the African Group. Document TN/C/W/59.
|
| [96] | Patterson DJ, Cooper J, Kirk PM, Pyle RL, Remsen DP (2010) Names are key to the big new biology. Trends in Ecology & Evolution 25: 686–691.
|
| [97] | Bisby FA, Roskov YR, Orrell TM, Nicolson D, Paglinawan LE, et al. (2011) Species 2000 & ITIS Catalogue of Life: 2011 Annual Checklist. Digital resource at www.catalogueoflife.org/annual-checklist？/2011/. Species 2000: Reading, UK.
|
| [98] | Chapman AD (2009) Numbers of living species in Australia and the world. Canberra: Australian Biological Resources Study.
|
| [99] | Mora C, Tittensor DP, Adl S, Simpson AGB, Worm B (2011) How Many Species Are There on Earth and in the Ocean? PLoS Biol 9 (8): e1001127 doi:10.1371/journal.pbio.1001127.
|
| [100] | Tanne JH (2012) How collaboration is providing new drugs for neglected diseases. British Medical Journal 344: 2.
|
| [101] | Norman FF, Perez de Ayala A, Perez-Molina J-A, Monge-Maillo B, Zamarron P, et al. (2010) Neglected Tropical Diseases outside the Tropics. PLoS Negl Trop Dis 4(7): e762 doi:10.1371/journal.pntd.0000762.
|
| [102] | Yacoub S, Kotit S, Yacoub MH (2011) Disease appearance and evolution against a background of climate change and reduced resources. Philosophical Transactions of the Royal Society A-Mathematical Physical and Engineering Sciences 369: 1719–1729.
|
| [103] | Kobets T, Grekov I, Lipoldova M (2012) Leishmaniasis: Prevention, Parasite Detection and Treatment. Current Medicinal Chemistry 19: 1443–1474.
|
| [104] | Malvy D, Chappuis F (2011) Sleeping sickness. Clinical Microbiology and Infection 17: 986–995.
|
| [105] | Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, et al (2008) Helminth infections: the great neglected tropical diseases. J Clin Invest 118: 1311.
|
| [106] | Fahal AH (2004) Mycetoma: a thorn in the flesh. Transactions of the Royal Society of Tropical Medicine and Hygiene 98: 3–11.
|
| [107] | Francesconi F, Lupi O (2012) Myiasis. Clinical Microbiology Reviews 25: 79–105.
|
| [108] | Rezaie R, McGahan AM, Frew SE, Daar AS, Singer PA (2012) Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators. Health Research Policy and Systems 10: 18 doi:–––10.1186/1478–4505–10–18.
|
| [109] | de Magalhaes JL, Boechat N, Antunes AMD (2012) Identification of Brazilian expertise in the fight against some neglected tropical diseases. Revista da Sociedade Brasileira de Medicina Tropical 45: 415–417.
|
| [110] | Lindoso JAL, Lindoso A (2009) Neglected Tropical Diseases in Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo 51: 247–253.
|
| [111] | Kettler HE, Modi R (2001) Building local research and development capacity for the prevention and cure of neglected diseases: the case of India. Bulletin of the World Health Organization 79: 742–747.
|
| [112] | Lobo DA, Velayudhan R, Chatterjee P, Kohli H, Hotez PJ (2011) The Neglected Tropical Diseases of India and South Asia: Review of heir Prevalence, Distribution, and Control or Elimination. PLoS Negl Trop Dis 5(10): e1222 doi:10.1371/journal.pntd.0001222.
|
| [113] | Wang LD, Guo JG, Wu XH, Chen HG, Wang TP, et al. (2009) China’s new strategy to block Schistosoma japonicum transmission: experiences and impact beyond schistosomiasis. Tropical Medicine & International Health 14: 1475–1483.
|
| [114] | Newman DJ, Cragg GM (2012) Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010. J Nat Prod 75: 311–335.
|
| [115] | Laird SA, Wynberg R (2008) Access and benefit-sharing in practice: trends in partnerships across sectors. Montreal, Québec, Canada: Secretariat of the Convention on Biological Diversity.
|
| [116] | Gupta RK (2004) Surge in US patents on botanicals. Nature Biotechnology 22: 653–654.
|
| [117] | Oldham P, Cutter A (2006) Mapping global status and trends in patent activity for biological and genetic material. Genomics, Society and Policy 2: 62–91.
|
| [118] | Davis AP, Rakotonasolo F (2001) Three new species of Coffea L.(Rubiaceae) from NE Madagascar. Adansonia 23: 137–146.
|
| [119] | Hamilton CJ (2007) Knowledge, ownership and life: the relationship between biopiracy and intellectual property rights. Ph.D. thesis. London School of Economics and Political Science (University of London).
|
| [120] | United Nations General Assembly (1962) Permanent sovereignty over natural resources. General Assembly Resolution 1803 ((XVII) of 14 December 1962.
|
| [121] | Schrijver N (1997) Sovereignty over natural resources: balancing rights and duties. Cambridge; New York: Cambridge University Press.
|
| [122] | Cullet P (2007) Human rights and intellectual property protection in the TRIPS era. Human Rights Quarterly 29: 403–430.
|
| [123] | Zainol ZA, Amin L, Akpoviri F, Ramli R (2011) Biopiracy and states’ sovereignty over their biological resources. African Journal of Biotechnology 10: 12395–12408.
|
| [124] | Kursar TA (2011) What Are the Implications of the Nagoya Protocol for Research on Biodiversity? Bioscience 61: 256–257.
|
| [125] | Lorence A, Nessler CL (2004) Molecules of interest - Camptothecin, over four decades of surprising findings. Phytochemistry 65: 2735–2749.
|
| [126] | Vleggaar R, Ackerman Lgj, Steyn Ps (1992) Structure Elucidation of Monatin, a High-Intensity Sweetener Isolated from the Plant Schlerochiton-Ilicifolius. Journal of the Chemical Society-Perkin Transactions 1: 3095–3098.
|
| [127] | Fry JC, Yurttas N, Biermann KL, Lindley MG, Goulson MJ (2012) The Sweetness Concentration-Response of R,R-Monatin, a Naturally Occurring High-Potency Sweetener. Journal Of Food Science 77 (10) S362–S364.
|
| [128] | Krumlauf R (1994) Hox Genes In Vertebrate Development. Cell 78: 191–201.
|
| [129] | Williams JGK, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV (1990) DNA Polymorphisms Amplified By Arbitrary Primers Are Useful As Genetic-Markers. Nucleic Acids Research 18: 6531–6535.
|
| [130] | Oldham P (2004) Global status and trends in intellectual property claims: genomics, proteomics and biotechnology. UNEP/CBD/WG-ABS/3/INF/4.
|
| [131] | Jensen K, Murray F (2005) Intellectual property landscape of the human genome. Science 310: 239–240.
|
| [132] | Cook-Deegan R, Heaney C (2010) Patents in Genomics and Human Genetics. Annual Review of Genomics and Human Genetics 11: 383–425.
|
| [133] | Kean S (2011) The Human Genome (Patent) Project. Science 331: 530–531.
|
| [134] | Konski AF, Spielthenner DJF (2009) Stem cell patents: a landscape analysis. Nature Biotechnology 27: 722–727.
|
| [135] | Marshall E (2012) U.S. Appeals Court Hears Gene Patent Arguments. Science 337: 277–278.
|
| [136] | Moran N (2012) Affymax poised to challenge Amgen. Nature Biotechnology 30: 377–379.
|
| [137] | Conley JM, Makowski R (2003) Back to the Future: Rethinking the Product of Nature Doctrine as a Barrier to Biotechnology Patents (Part I). 85 J. Pat. & Trademark Off. Soc’y 371.
|
| [138] | Cook-Deegan R (2012) Law and Science Collide Over Human Gene Patents. Science 338: 745–747.
|
| [139] | Supreme Court of the United States (2013) Syllabus: Association for Molecular Pathology et al,. v. Myriad Genetics, Inc. et al. No. 12–398. Decided June 13, 2013.
|
| [140] | Ledford H (2013) Myriad ruling causes confusion. Nature 498: 281–282.
|
| [141] | FAOSTAT 2012 GPS2.
|
| [142] | Food and Agriculture Organization (2004) The State of Food and Agriculture 2003–2004: Agricultural Biotechnology - Meeting the Needs of the Poor? Rome: Food and Agriculture Organization of the United Nations.
|
| [143] | Food and Agriculture Organization (2010) The State of Food Insecurity in the World. Rome: Food and Agriculture Organization of the United Nations.
|
| [144] | Food and Agriculture Organization (2011) Biotechnologies for agricultural development: proceedings of the FAO international technical conference on “agricultural biotechnologies in developing countries: options and opportunities in crops, forestry, livestock, fisheries and agro-industry to face the challenges of food insecurity and climate change”: ABDC-10. Rome: Food and Agriculture Organization of the United Nations.
|
| [145] | Pineyro-Nelson A, Van Heerwaarden J, Perales HR, Serratos-Hernandez JA, Rangel A, et al. (2009) Transgenes in Mexican maize: molecular evidence and methodological considerations for GMO detection in landrace populations. Mol Ecol 18: 750–761.
|
| [146] | Howard PH (2009) Visualizing Consolidation in the Global Seed Industry: 1996–2008. Sustainability 1: 1266–1287.
|
| [147] | ETC Group (2013) Gene Giants Seek “Philanthrogopoly”. Montreal: ETC Group.
|
| [148] | Esquinas-Alcázar J (2005) Protecting crop genetic diversity for food security: political, ethical and technical challenges. Nature Reviews Genetics 6: 946–953.
|
| [149] | Hammer K, Heller J, Engels J (2001) Monographs on underutilized and neglected crops. Genetic Resources and Crop Evolution. 48: 3–5.
|
| [150] | Mayes S, Massawe FJ, Alderson PG, Roberts JA, Azam-Ali SN, et al. (2012) The potential for underutilized crops to improve security of food production. J Exp Bot 63: 1075–1079.
|
| [151] | Moeller N, Stannard C (eds.) (2013) Identifying Benefit Flows: Studies on the Potential Monetary and Nonmonetary Benefits Arising from the International Treaty on Plant Genetic Resources for Food and Agriculture. Rome: International Treaty on Plant Genetic Resources for Food and Agriculture of the Food and Agriculture Organization.
|
| [152] | Jack BK, Kousky C, Sims KR (2008) Designing payments for ecosystem services: Lessons from previous experience with incentive-based mechanisms. Proc. Natl. Acad. Sci. USA 105: 9465–9470.
|
| [153] | Gilbert P, McBain AJ (2003) Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clinical Microbiology Reviews 16(2): 189–208.
|
| [154] | Sarmah AK, Meyer MT, Boxall A (2006) A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 65: 725–759.
|
| [155] | Relyea RA (2009) A cocktail of contaminants: how mixtures of pesticides at low concentrations affect aquatic communities. Oecologia 159: 363–376.
|
| [156] | Palmer MJ, Moffat C, Saranzewa N, Harvey J, Wright GA et al (2013) Cholinergic pesticides cause mushroom body neuronal inactivation in honeybees. Nature Communications 4: 1634 doi:10.1038/ncomms2648.
|
| [157] | Dicks L (2013) Bees, lies and evidence-based policy. Nature 494: 283.
|
| [158] | Cressey D (2013) Europe debates risk to bees. Nature 496: 408.
|
| [159] | Blunt JW, Copp BR, Keyzers RA, Munro MHG, Prinsep MR (2012) Marine natural products. Natural Product Reports 29: 144–222.
|
| [160] | Shimomura O, Johnson FH, Saiga Y (1962) Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. Journal of cellular and comparative physiology 59: 223–239.
|
| [161] | Ward WW, Cormier MJ (1975) Extraction of Renilla-type luciferin from the calcium-activated photoproteins aequorin, mnemiopsin, and berovin. Proc. Natl. Acad. Sci. USA 72: 2530–2534.
|
| [162] | Oren A (2005) A hundred years of Dunaliella research: 1905–2005. Saline Systems 1: 2 doi:10.1186/1746-1448-1-2.
|
| [163] | De Swaaf M, Pronk J, Sijtsma L (2003) Fed-batch cultivation of the docosahexaenoic-acid-producing marine alga Crypthecodinium cohnii on ethanol. Appl Microbiol Biotechnol 61: 40–43.
|
| [164] | Gerber GS, Fitzpatrick JM (2004) The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia. BJU international 94: 338–344.
|
| [165] | Sukumaran S, Pittman KB, Patterson WK, Dickson J, Yeend S, et al. (2010) A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancer. Ann Oncol 21: 1089–1093.
|
| [166] | Brien S, Prescott P, Coghlan B, Bashir N, Lewith G (2008) Systematic review of the nutritional supplement Perna Canaliculus (green-lipped mussel) in the treatment of osteoarthritis. QJM 101: 167–179.
|
| [167] | Hartline K (1969) Visual Receptors and Retinal Interaction. Science 164: 270–278.
|
| [168] | van de Velde F, De Ruiter GA (2005) Carrageenan. Biopolymers Online. doi:10.1002/3527600035.bpol6009.
|
| [169] | Arico S, Salpin C (2005) Bioprospecting of genetic resources in the deep seabed: scientific, legal and policy aspects. Tokyo: United Nations University Institute of Advanced Studies.
|
| [170] | Leary D, Vierros M, Hamon G, Arico S, Monagle C (2009) Marine genetic resources: A review of scientific and commercial interest. Marine Policy 33: 183–194.
|
| [171] | United Nations General Assembly (2007) United Nations Declaration on the Rights of Indigenous Peoples. United Nations.
|
| [172] | Ellis R, Waterton C (2004) Environmental citizenship in the making: the participation of volunteer naturalists in UK biological recording and biodiversity policy. Science And Public Policy 31: 95–105.
|
| [173] | Hemment D, Ellis R, Wynne B (2011) Participatory Mass Observation And Citizen Science. Leonardo 44: 62–63.
|
| [174] | Snaddon J, Petrokofsky G, Jepson P, Willis KJ (2013) Biodiversity technologies: tools as change agents. Biology Letters 9. doi:10.1098/rsbl.2012.1029.
|
| [175] | Juma C (1989) The Gene Hunters: biotechnology and the scramble for seeds. Princeton, N.J.: Princeton University Press.
|
| [176] | Heckler S (ed.) (2009) Landscape, Process and Power Re-evaluating Traditional Environmental Knowledge. New York; Oxford: Berghahn Books.
|
| [177] | Heller M (2013) The Tragedy of the Anticommons: A Concise Introduction and Lexicon. Modern Law Review 76: 6–25.
|
| [178] | Posey D (ed.) (1999) Cultural and spiritual values of biodiversity. London: Intermediate Technology.
|
| [179] | Maffi L, Woodley E (2010) Biocultural diversity conservation : a global sourcebook. London; Washington, D.C.: Earthscan.
|
| [180] | Millennium Ecosystem Assessment MEA (2005) Ecosystems and human well-being: synthesis. Washington DC: Island Press.
|
| [181] | Laird S (ed.) (2002) Biodiversity and Traditional Knowledge: Equitable Partnerships in Practice. London: Routledge.
|
| [182] | Arbour L, Cook D (2006) DNA on loan: issues to consider when carrying out genetic research with aboriginal families and communities. Public Health Genomics 9: 153–160.
|
| [183] | Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada (2010) Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, December 2010.
|
| [184] | Secretariat of the Convention on Biological Diversity (2011) Tkarihwaié:ri Code of Ethical Conduct to Ensure Respect for the Cultural and Intellectual Heritage of Indigenous and Local Communities Relevant to the Conservation and Sustainable Use of Biological Diversity. Montreal: Secretariat of the Convention on Biological Diversity.
|
| [185] | European Commission (2012) Proposal for a Regulation of the European Parliament and of the Council on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization in the Union (COM 2012 576 final). Brussels: European Commission.
|
| [186] | Oldham P, Burton G (2010) Defusing Disclosure in Patent Applications. UNEP/CBD/COP/10/INF/44.
|
| [187] | Athreye S, Yang Y (2011) Disembodied Knowledge Flows in the World Economy. WIPO Economic Research Working Papers No. 3. Geneva: World Intellectual Property Organization.
|
| [188] | OECD (2012) OECD science, technology, and industry outlook 2012. 2012. Paris: OECD Publishing.
|
| [189] | Oldham P (2006) Biodiversity and the patent system: towards international indicators. Global Status and Trends in Intellectual Property Claims 3 1–88: UNEP/CBD/WG–ABS/5/INF/6.
|
| [190] | Scotchmer S (2004) Innovation and incentives. Cambridge, Mass.: MIT Press.
|
| [191] | Chesbrough H (2012) Open Innovation Where We’ve Been and Where We’re Going. Research-Technology Management 55 (4): 20–27.
|
| [192] | Maurer SM, Scotchmer S (2006) Open source software: the new intellectual property paradigm. National Bureau of Economic Research, NBER Working Paper No. W12148.
|
| [193] | Lerner J, Tirole J (2002) Some simple economics of open source. The Journal of Industrial Economics 50: 197–234.
|
| [194] | Lerner J, Tirole J (2005) The economics of technology sharing: Open source and beyond. Journal of Economic Perspectives 19: 99–120.
|
| [195] | Bhardwaj A, Scaria V, Raghava GPS, Lynn AM, Chandra N, et al. (2011) Open source drug discovery- A new paradigm of collaborative research in tuberculosis drug development. Tuberculosis 91: 479–486.
|
| [196] | Oldham P (2009) An Access and Benefit Sharing Commons? The Role of Commons/Open Source Licenses in the International Regime on Access to Genetic Resources and Benefit-Sharing. Initiative for the Prevention of Biopiracy, Research Documents 4: UNEP/CBD/WG–ABS/8/INF/3.
|
| [197] | Hilgartner S (2012) Novel constitutions? New regimes of openness in synthetic biology. Biosocieties 7: 188–207.
|
| [198] | Calvert J (2012) Ownership and sharing in synthetic biology: A ‘diverse ecology’ of the open and the proprietary? Biosocieties 7: 169–187.
|
| [199] | Warren R, VanDerWal J, Price J, Welbergen JA, Atkinson I, et al. (2013) Quantifying the benefit of early climate change mitigation in avoiding biodiversity loss. Nature Climate Change 3: 678–682 doi:10.1038/nclimate1887.
|
| [200] | Falkowski P (2012) Q&A: A slow-motion crisis. Nature 483: S21–S21 doi:10.1038/483S21a.
|
